Title: Pipeline Review on Diabetic Gastroparesis Therapeutic Industry, H1 2014
1Diabetic Gastroparesis - Pipeline Review, H1 2014
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
- Published January 2014
- Single User PDF US 2000
- Corporate User PDF US 6000
2 Diabetic Gastroparesis - Pipeline Review,
H1 2014
- Diabetic Gastroparesis - Pipeline Review, H1 2014
provides an overview of the indications
therapeutic pipeline. This report provides
information on the therapeutic development for
Diabetic Gastroparesis, complete with latest
updates, and special features on late-stage and
discontinued projects. It also reviews key
players involved in the therapeutic development
for Diabetic Gastroparesis. Diabetic
Gastroparesis- Pipeline Review, Half Year is
built using data and information sourced from
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by research team. - Scope
- A snapshot of the global therapeutic scenario for
Diabetic Gastroparesis. - A review of the Diabetic Gastroparesis products
under development by companies and
universities/research institutes based on
information derived from company and
industry-specific sources. - Coverage of products based on various stages of
development ranging from discovery till
registration stages. - A feature on pipeline projects on the basis of
monotherapy and combined therapeutics. - Inquiry Before Buying on this Report _at_
http//www.reportsnreports.com/contacts/InquiryBef
oreBuy.aspx?name274907
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
3 Diabetic Gastroparesis - Pipeline Review,
H1 2014
- Coverage of the Diabetic Gastroparesis pipeline
on the basis of route of administration and
molecule type. - Key discontinued pipeline projects.
- Latest news and deals relating to the products.
- Reasons to buy
- Identify and understand important and diverse
types of therapeutics under development for
Diabetic Gastroparesis. - Identify emerging players with potentially strong
product portfolio and design effective
counter-strategies to gain competitive advantage. - Plan mergers and acquisitions effectively by
identifying players of the most promising
pipeline. - Devise corrective measures for pipeline projects
by understanding Diabetic Gastroparesis pipeline
depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing
strategies by identifying prospective partners
with the most attractive projects to enhance and
expand business potential and scope. - Modify the therapeutic portfolio by identifying
discontinued projects and understanding the
factors that drove them from pipeline. - Inquire for Discount _at_ http//www.reportsnreports.
com/contacts/Discount.aspx?name274907 -
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
4 Diabetic Gastroparesis - Pipeline Review,
H1 2014
- List of Tables
- Number of Products under Development for Diabetic
Gastroparesis, H1 2014 7 - Number of Products under Development for Diabetic
Gastroparesis - Comparative Analysis, H1 2014 - Number of Products under Development by
Companies, H1 2014 9 - Comparative Analysis by Late Stage Development,
H1 2014 10 - Comparative Analysis by Clinical Stage
Development, H1 2014 11 - Comparative Analysis by Early Stage Development,
H1 2014 12 - Comparative Analysis by Unknown Stage
Development, H1 2014 13 - Products under Development by Companies, H1 2014
14 - Diabetic Gastroparesis - Pipeline by Theravance,
Inc., H1 2014 15 - Diabetic Gastroparesis - Pipeline by Evoke
Pharma, Inc., H1 2014 16 - Diabetic Gastroparesis - Pipeline by Targacept,
Inc., H1 2014 17 - Diabetic Gastroparesis - Pipeline by Cempra,
Inc., H1 2014 18 - Diabetic Gastroparesis - Pipeline by Rhythm
Pharmaceuticals, H1 2014 19 - Assessment by Monotherapy Products, H1 2014 20
- Number of Products by Stage and Mechanism of
Action, H1 2014 24
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
5 Diabetic Gastroparesis - Pipeline Review,
H1 2014
- Number of Products by Stage and Route of
Administration, H1 2014 26 - Number of Products by Stage and Molecule Type, H1
2014 28 - Number of Products by Stage and Therapeutic
Class, H1 2014 31 - Diabetic Gastroparesis Therapeutics - Recent
Pipeline Updates, H1 2014 38 - Diabetic Gastroparesis - Dormant Projects, H1
2014 42 - Diabetic Gastroparesis - Discontinued Products,
H1 2014 43 - List of Figures
- Number of Products under Development for Diabetic
Gastroparesis, H1 2014 7 - Number of Products under Development for Diabetic
Gastroparesis - Comparative Analysis, H1 2014 8 - Number of Products under Development by
Companies, H1 2014 9 - Assessment by Monotherapy Products, H1 2014 20
- Number of Products by Top 10 Target, H1 2014 21
- Number of Products by Stage and Top 10 Target, H1
2014 22 - Number of Products by Top 10 Mechanism of Action,
H1 2014 23
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
6 Diabetic Gastroparesis - Pipeline Review,
H1 2014
- Number of Products by Stage and Top 10 Mechanism
of Action, H1 2014 24 - Number of Products by Top 10 Route of
Administration, H1 2014 25 - Number of Products by Stage and Top 10 Route of
Administration, H1 2014 26 - Number of Products by Top 10 Molecule Type, H1
2014 27 - Number of Products by Stage and Top 10 Molecule
Type, H1 2014 28 - Number of Products by Top 10 Therapeutic Class,
H1 2014 29 - Number of Products by Stage and Top 10
Therapeutic Class, H1 2014 30 - Complete report of 51 Pages is available _at_
http//www.reportsnreports.com/reports/274907-diab
etic-gastroparesis-pipeline-review-h1-2014.html .
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.